On Wednesday, The S&P 500 traded near 2,090 as all ten sectors declined. The Dow Jones industrial average dropped down more than 150 points with all blue chips lagging.
“I’m expecting a lot of volatility recently,” said Peter Cardillo, chief market economist at Rockwell Global Capital. “All of this should happen as the flow of economic data keeps the market in a choppy and volatile session.”
Insights about U.S. Stocks that are active during the current trade, are depicted underneath:
Bank of America Corp (NYSE:BAC)’s shares declined -1.13%, and is now trading at $15.82. The Stock is active as 15.39M shares changed hands versus its average volume of 99.87M. The company holds the market capitalization of 166.31B. The stock return on equity value is 1.70%, while return on assets value is 0.20%, in response to its return on investment value of 7.60%. Its 20-day moving average declined -2.41%, and the stock moved below 50-day moving average of -3.79%. The mean recommendation of analysts for this stock is 2.30.(where 1=Buy, 5=Sale).
Bank of America Corporation, through its auxiliaries, provides banking and financial products and services for individual consumers, small and middle market businesses, institutional investors, large corporations, and governments worldwide.
Oasis Petroleum Inc (NYSE:OAS), dropped -2.75%, and is now trading at $13.48. The Stock is active as 11.54M shares changed hands versus its average volume of 11.09M.
Today, Oasis Petroleum Inc, declared that it has priced an upsized underwritten public offering of 32,000,000 shares of ordinary stock for total gross proceeds (before the underwriter’s discounts and commissions and estimated offering expenses) of about $409.6 million. Oasis intends to use the net proceeds of this offering to repay outstanding borrowings under its credit facility and for general corporate purposes. Oasis granted the underwriters a 30-day option to purchase up to 4,800,000 additional shares of ordinary stock. The offering is predictable to close on March 9, 2015.
Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC are acting as book-running managers for the offering.
Entities associated with SPO Advisory Corp. have agreed to purchase an aggregate of 8,000,000 shares of the ordinary stock offered in the offering at the price offered to the public. The offering is being made following an effective shelf registration statement, which has been filed and became effective July 15, 2014. The offering will be made only by means of a preliminary prospectus supplement and the accorporationing base prospectus, copies of which may be obtained on the Securities and Exchange Commission’s website at www.sec.gov.
Oasis is an independent exploration and production corporation focused on the attainment and development of unconventional oil and natural gas resources, primarily operating in the Williston Basin.
Ford Motor Company (NYSE:F), dipped -1.05%, and is now trading at $16.00. The Stock is active as 6.24M shares changed hands versus its average volume of 28.58M. The company holds the book value per share of 6.36, whereas cash per share is 2.72. Price to book value is estimated to be 2.54, while price to sale value is 0.44. Analysts mean recommendation for the stock is said to be 2.60 (where 1=Buy, 5=sale).
Ford Motor Company, is collaborating with the National Veterans Transition Services, Inc. on a three-week workshop designed specifically to address the issues women veterans face as a growing number of them are returning to civilian life and a possibly uncertain future.
The Freedom’s Sisters REBOOT Workshop runs from March 9-27 on the campus of National University here. Up to 25 women veterans will be able to attend free classes five days a week that focus on employment and career, personal well-being, achieving aims. Also comprised of is a personal makeover session to ease the move back to civilian dress from military uniforms.
A report from the Disabled American Veterans in September 2014 said that the country’s nearly 300,000 female veterans face greater challenges than their male counterparts when they re-enter civilian life because they experience the rigors of deployment and reintegration differently.
As a group contrast to men, women veterans are less likely to be married, and are more likely to be single parents and unemployed. In addition to higher rates of homelessness, they also often face gaps in medical care for women’s health issues as they enter a veterans system geared toward treating males. These issues are predictable to grow as the number of women veterans raises. Women are predictable to comprise 11 percent of the veteran population by 2020, up from 9 percent now.
“These brave women have served and sacrificed to defend our freedom, and yet there are few programs that address their unique needs as they return to the home front and to their families,” said Pamela Alexander, director of Community Development, Ford Motor Corporation Fund. “It’s another opportunity to say thank you, while also assisting them make a successful transition.”
Ford Motor Company (NYSE:F), a global automotive industry leader based in Dearborn, Michigan manufactures or distributes automobiles across six continents. With about 187,000 employees and 62 plants worldwide, the corporation’s automotive brands comprise Ford and Lincoln. The corporation provides financial services through Ford Motor Credit Corporation.
Orexigen Therapeutics, Inc (NASDAQ:OREX), enhanced 12.76%, and is now trading at $8.49. The Stock is active as 10.32M shares changed hands versus its average volume of 5.06M. The company has the market capitalization of $1.07B. The beta value of the stock is 2.47. On the other hand the stock’s volatility for the week is 15.84%, and for the month is 7.46%. The stock price to book value is $54.57, however price to sale value is $17.00. Analyst’s mean recommendation regarding this stock is 1.60. (where 1=Buy, 5=Sale).
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Orexigen developed Contrave® (naltrexone HCl and bupropion HCl extended release), which is approved in the United States and is being commercialized there by the company’s North American partner, Takeda Pharmaceuticals. In Europe the drug is being reviewed for marketing authorization under the brand name MysimbaTM (naltrexone HCl/ bupropion HCl prolonged release).
